Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Inventory of $276000.0 for Q1 2026, up 37.31% year-over-year from $201000.0 in Q1 2025, and down 1.78% quarter-over-quarter from $281000.0 in Q4 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Inventory for 8 consecutive years, with $276000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 37.31% year-over-year to $276000.0; the TTM figure through Mar 2026 stood at $276000.0 (up 37.31% YoY), while the FY2025 annual figure was $281000.0, up 21.65% from the prior year.
- Inventory declined to $276000.0 in Q1 2026 per LXRX's latest filing, from $281000.0 in the prior quarter.
- Across five years, Inventory topped out at $636000.0 in Q3 2024 and bottomed at $158000.0 in Q3 2025.
- Historically, Inventory has averaged $328250.0 across 4 years, with a median of $278500.0 in 2025.
- Annual changes were most pronounced in 2024 — Inventory soared 240.12% — and 2025, when it plunged 75.16%.
- Lexicon Pharmaceuticals' Inventory stood at $381000.0 in 2023, then tumbled by 39.37% to $231000.0 in 2024, then grew by 21.65% to $281000.0 in 2025, then dropped by 1.78% to $276000.0 in 2026.
- Business Quant data shows LXRX's Inventory at $276000.0 in Q1 2026, $281000.0 in Q4 2025, and $158000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 276,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 201,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 636,000.00 |
| Jun 30, 2024 | 585,000.00 |
| Mar 31, 2024 | 514,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 336,000.00 |
| Jun 30, 2023 | 172,000.00 |
| Jun 30, 2020 | 3.99 Mn |
| Mar 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 4.24 Mn |
| Sep 30, 2019 | 4.48 Mn |
| Jun 30, 2019 | 4.28 Mn |
| Mar 31, 2019 | 4.61 Mn |
| Dec 31, 2018 | 4.68 Mn |